sales@fnfresearch.comTel: +91 96043 17127 | USA: 1 (347) 690-0211

Search Market Research Report

Home / Category / Biotechnology / Next Generation Sequencing (NGS)

Next Generation Sequencing (NGS) Market By Products and Services (Products by Technology and Sequencing Services by Type), By Application (Bioinformatics, Genetic Research, Diagnostics, Agriculture & Animal Research, and Drug Discovery), and By End-User (Research Institutes, Academic Institutes, Pharmaceuticals, Hospitals, and Biotechnology Companies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018 – 2027

  • Publish On: Nov-2019
  • Total Pages: 190
  • Report Code: FAF-148
  • Base Year: 2018
  • Format:

Industry Insights

The report covers the forecast and analysis of the next generation sequencing (NGS) market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the next generation sequencing (NGS) market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the next generation sequencing (NGS) market on a global level.

In order to give the users of this report a comprehensive view of the biometric payment market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product & service launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the next generation sequencing (NGS) market by segmenting the market based on the products and services, application, end-user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

The massive utilization of cloud technology for storing huge volume of genome data is likely to enhance the expansion of the next generation sequencing (NGS) industry during the period from 2019 to 2027. Large-scale investments in NGS technologies by the National Human Genome Research Institute were made to widen the utility of genome sequencing data in the clinical practice of medicine. The plethora of applications of NGS for diagnosing ailments like Cancer, psychiatry, cardiology, hematological disorders, hearing impairment, dysmorphology,  cardiology, vision & hearing impairment, and pharmacogenomics will amplify the business growth. Nonetheless, the less availability of experts will impede the expansion of the market during the period from 2019 to 2027. In addition to this, short average read lengths are anticipated to put brakes on the market during the forecast timeline.

Based on the products and services, the market is sectored into Products by Technology and Sequencing Services by Type. Application-wise, the industry is divided into Bioinformatics, Genetic Research, Diagnostics, Agriculture & Animal Research, and Drug Discovery. In terms of end-user, the market is classified into Research Institutes, Academic Institutes, Pharmaceuticals, Hospitals, and Biotechnology Companies.

Global Next Generation Sequencing (NGS) : Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Key Features of Next Generation Sequencing (NGS) Report:

  • Next Generation Sequencing (NGS) structure: Overview, industry life cycle analysis, supply chain analysis
  • Next Generation Sequencing (NGS) : Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Next Generation Sequencing (NGS) size, trend, and forecast analysis
  • Next Generation Sequencing (NGS) segments’ trend and forecast
  • Next Generation Sequencing (NGS) ’s competitive landscapes: Market share, Product portfolio, New product launches, etc.
  • Next Generation Sequencing (NGS) attractiveness and associated growth opportunities
  • Emerging trends in the Next Generation Sequencing (NGS) .
  • Strategic growth opportunities for the existing and new players
  • Key success factors

Benefits of Buying from Facts & Factors:

  • Our proven methodologies and systematic analysis help in making confident business and strategic decisions.
  • A market study that conducts at Facts & Factors Market Research can save significant cost and time, and can help prevent making costly mistakes.

Table of Content

  • Chapter 1. Executive Summary 21
  • Chapter 2. Next Generation Sequencing (NGS) market – Products and Services Analysis 24
    • 2.1. Global Next Generation Sequencing (NGS) Market – Products and Services Overview 24
    • 2.2. Global Next Generation Sequencing (NGS) Market Share, by Products and Services, 2018 & 2025 (USD Million) 24
    • 2.3. Products by Technology 26
      • 2.3.1. Global Products by Technology Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 26
    • 2.4. Sequencing Services by Type 27
      • 2.4.1. Global Sequencing Services by Type Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 27
  • Chapter 3. Next Generation Sequencing (NGS) market – Application Analysis 27
    • 3.1. Global Next Generation Sequencing (NGS) Market – Application Overview 27
    • 3.2. Global Next Generation Sequencing (NGS) Market Share, by Application, 2018 & 2025 (USD Million) 28
    • 3.3. Bioinformatics 29
      • 3.3.1. Global Bioinformatics Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 29
    • 3.4. Genetic Research 30
      • 3.4.1. Global Genetic Research Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 30
    • 3.5. Diagnostics 31
      • 3.5.1. Global Diagnostics Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 31
    • 3.6. Agriculture & Animal Research 32
      • 3.6.1. Global Agriculture & Animal Research Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 32
    • 3.7. Drug Discovery 33
      • 3.7.1. Global Drug Discovery Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 33
  • Chapter 4. Next Generation Sequencing (NGS) market – End-User Analysis 33
    • 4.1. Global Next Generation Sequencing (NGS) Market – End-User Overview 33
    • 4.2. Global Next Generation Sequencing (NGS) Market Share, by End-User, 2018 & 2025 (USD Million) 34
    • 4.3. Research Institutes 35
      • 4.3.1. Global Research Institutes Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 35
    • 4.4. Academic Institutes 36
      • 4.4.1. Global Academic Institutes Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 36
    • 4.5. Pharmaceuticals 37
      • 4.5.1. Global Pharmaceuticals Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 37
    • 4.6. Hospitals 38
      • 4.6.1. Global Hospitals Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 38
    • 4.7. Biotechnology Companies 39
      • 4.7.1. Global Biotechnology Companies Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 39
  • Chapter 5. Next Generation Sequencing (NGS) market – Regional Analysis 40
    • 5.1. Global Next Generation Sequencing (NGS) Market Regional Overview 40
    • 5.2. Global Next Generation Sequencing (NGS) Market Share, by Region, 2018 & 2025 (Value) 40
    • 5.3. North America 42
      • 5.3.1. North America Next Generation Sequencing (NGS) Market size and forecast, 2015-2027 42
      • 5.3.2. North America Next Generation Sequencing (NGS) Market, by Country, 2018 & 2025 (USD Million) 42
      • 5.3.3. North America Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 44
        • 5.3.3.1. North America Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 44
      • 5.3.4. North America Next Generation Sequencing (NGS) Market, by Application, 2015-2027 45
        • 5.3.4.1. North America Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 45
      • 5.3.5. North America Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 46
        • 5.3.5.1. North America Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 46
      • 5.3.6. U.S. 47
        • 5.3.6.1. U.S. Market size and forecast, 2015-2027 (USD Million) 47
      • 5.3.7. Canada 48
        • 5.3.7.1. Canada Market size and forecast, 2015-2027 (USD Million) 48
      • 5.3.8. Mexico 49
        • 5.3.8.1. Mexico Market size and forecast, 2015-2027 (USD Million) 49
    • 5.4. Europe 50
      • 5.4.1. Europe Next Generation Sequencing (NGS) Market size and forecast, 2015-2027 50
      • 5.4.2. Europe Next Generation Sequencing (NGS) Market, by Country, 2018 & 2025 (USD Million) 50
      • 5.4.3. Europe Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 52
        • 5.4.3.1. Europe Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 52
      • 5.4.4. Europe Next Generation Sequencing (NGS) Market, by Application, 2015-2027 53
        • 5.4.4.1. Europe Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 53
      • 5.4.5. Europe Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 54
        • 5.4.5.1. Europe Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 54
      • 5.4.6. Germany 55
        • 5.4.6.1. Germany Market size and forecast, 2015-2027 (USD Million) 55
      • 5.4.7. France 56
        • 5.4.7.1. France Market size and forecast, 2015-2027 (USD Million) 56
      • 5.4.8. U.K. 57
        • 5.4.8.1. U.K. Market size and forecast, 2015-2027 (USD Million) 57
      • 5.4.9. Italy 58
        • 5.4.9.1. Italy Market size and forecast, 2015-2027 (USD Million) 58
      • 5.4.10. Spain 59
        • 5.4.10.1. Spain Market size and forecast, 2015-2027 (USD Million) 59
      • 5.4.11. Nordic Countries 60
        • 5.4.11.1. Nordic Countries Market size and forecast, 2015-2027 (USD Million) 60
      • 5.4.12. Benelux Union 61
        • 5.4.12.1. Benelux Union Market size and forecast, 2015-2027 (USD Million) 61
      • 5.4.13. Rest of Europe 62
        • 5.4.13.1. Rest of Europe Market size and forecast, 2015-2027 (USD Million) 62
    • 5.5. Asia Pacific 63
      • 5.5.1. Asia Pacific Next Generation Sequencing (NGS) Market size and forecast, 2015-2027 63
      • 5.5.2. Asia Pacific Next Generation Sequencing (NGS) Market, by Country, 2018 & 2025 (USD Million) 63
      • 5.5.3. Asia Pacific Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 65
        • 5.5.3.1. Asia Pacific Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 65
      • 5.5.4. Asia Pacific Next Generation Sequencing (NGS) Market, by Application, 2015-2027 66
        • 5.5.4.1. Asia Pacific Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 66
      • 5.5.5. Asia Pacific Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 67
        • 5.5.5.1. Asia Pacific Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 67
      • 5.5.6. China 68
        • 5.5.6.1. China Market size and forecast, 2015-2027 (USD Million) 68
      • 5.5.7. Japan 69
        • 5.5.7.1. Japan Market size and forecast, 2015-2027 (USD Million) 69
      • 5.5.8. India 70
        • 5.5.8.1. India Market size and forecast, 2015-2027 (USD Million) 70
      • 5.5.9. New Zealand 71
        • 5.5.9.1. New Zealand Market size and forecast, 2015-2027 (USD Million) 71
      • 5.5.10. Australia 72
        • 5.5.10.1. Australia Market size and forecast, 2015-2027 (USD Million) 72
      • 5.5.11. South  Korea 73
        • 5.5.11.1. South  Korea Market size and forecast, 2015-2027 (USD Million) 73
      • 5.5.12. South-East Asia 74
        • 5.5.12.1. South-East Asia Market size and forecast, 2015-2027 (USD Million) 74
      • 5.5.13. Rest of Asia Pacific 75
        • 5.5.13.1. Rest of Asia Pacific Market size and forecast, 2015-2027 (USD Million) 75
    • 5.6. Latin America 76
      • 5.6.1. Latin America Next Generation Sequencing (NGS) Market size and forecast, 2015-2027 76
      • 5.6.2. Latin America Next Generation Sequencing (NGS) Market, by Country, 2018 & 2025 (USD Million) 76
      • 5.6.3. Latin America Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 78
        • 5.6.3.1. Latin America Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 78
      • 5.6.4. Latin America Next Generation Sequencing (NGS) Market, by Application, 2015-2027 79
        • 5.6.4.1. Latin America Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 79
      • 5.6.5. Latin America Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 80
        • 5.6.5.1. Latin America Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 80
      • 5.6.6. Brazil 81
        • 5.6.6.1. Brazil Market size and forecast, 2015-2027 (USD Million) 81
      • 5.6.7. Argentina 82
        • 5.6.7.1. Argentina Market size and forecast, 2015-2027 (USD Million) 82
      • 5.6.8. Rest of Latin America 83
        • 5.6.8.1. Rest of Latin America Market size and forecast, 2015-2027 (USD Million) 83
    • 5.7. The Middle-East and Africa 84
      • 5.7.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market size and forecast, 2015-2027 84
      • 5.7.2. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Country, 2018 & 2025 (USD Million) 84
      • 5.7.3. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 86
        • 5.7.3.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 86
      • 5.7.4. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Application, 2015-2027 87
        • 5.7.4.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 87
      • 5.7.5. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 88
        • 5.7.5.1. The Middle-East and Africa Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 88
      • 5.7.6. Saudi Arabia 89
        • 5.7.6.1. Saudi Arabia Market size and forecast, 2015-2027 (USD Million) 89
      • 5.7.7. UAE 90
        • 5.7.7.1. UAE Market size and forecast, 2015-2027 (USD Million) 90
      • 5.7.8. Egypt 91
        • 5.7.8.1. Egypt Market size and forecast, 2015-2027 (USD Million) 91
      • 5.7.9. Kuwait 92
        • 5.7.9.1. Kuwait Market size and forecast, 2015-2027 (USD Million) 92
      • 5.7.10. South Africa 93
        • 5.7.10.1. South Africa Market size and forecast, 2015-2027 (USD Million) 93
      • 5.7.11. Rest of Middle-East Africa 94
        • 5.7.11.1. Rest of Middle-East Africa Market size and forecast, 2015-2027 (USD Million) 94
  • Chapter 6. Next Generation Sequencing (NGS) market – Competitive Landscape 95
    • 6.1. Competitor Market Share – Revenue 95
    • 6.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players 97
    • 6.3. Strategic Development 98
      • 6.3.1. Acquisitions and Mergers 98
      • 6.3.2. New Products 98
      • 6.3.3. Research & Development Activities 98
  • Chapter 7. Company Profiles 99
    • 7.1. ABM Inc. 99
      • 7.1.1. Company Overview 99
      • 7.1.2. ABM Inc. Revenue and Gross Margin 99
      • 7.1.3. Product portfolio 100
      • 7.1.4. Recent initiatives 101
    • 7.2. Agilent Technologies Inc. 101
      • 7.2.1. Company Overview 101
      • 7.2.2. Agilent Technologies Inc. Revenue and Gross Margin 101
      • 7.2.3. Product portfolio 102
      • 7.2.4. Recent initiatives 103
    • 7.3. BD 103
      • 7.3.1. Company Overview 103
      • 7.3.2. BD Revenue and Gross Margin 103
      • 7.3.3. Product portfolio 104
      • 7.3.4. Recent initiatives 105
    • 7.4. BGI 105
      • 7.4.1. Company Overview 105
      • 7.4.2. BGI Revenue and Gross Margin 105
      • 7.4.3. Product portfolio 106
      • 7.4.4. Recent initiatives 107
    • 7.5. DNASTAR 107
      • 7.5.1. Company Overview 107
      • 7.5.2. DNASTAR Revenue and Gross Margin 107
      • 7.5.3. Product portfolio 108
      • 7.5.4. Recent initiatives 109
    • 7.6. Eurofins Genomics 109
      • 7.6.1. Company Overview 109
      • 7.6.2. Eurofins Genomics Revenue and Gross Margin 109
      • 7.6.3. Product portfolio 110
      • 7.6.4. Recent initiatives 111
    • 7.7. F. Hoffmann-La Roche Ltd. 111
      • 7.7.1. Company Overview 111
      • 7.7.2. F. Hoffmann-La Roche Ltd. Revenue and Gross Margin 111
      • 7.7.3. Product portfolio 112
      • 7.7.4. Recent initiatives 113
    • 7.8. Illumina Inc. 113
      • 7.8.1. Company Overview 113
      • 7.8.2. Illumina Inc. Revenue and Gross Margin 113
      • 7.8.3. Product portfolio 114
      • 7.8.4. Recent initiatives 115
    • 7.9. LGC Limited 115
      • 7.9.1. Company Overview 115
      • 7.9.2. LGC Limited Revenue and Gross Margin 115
      • 7.9.3. Product portfolio 116
      • 7.9.4. Recent initiatives 117
    • 7.10. Macrogen Inc. 117
      • 7.10.1. Company Overview 117
      • 7.10.2. Macrogen Inc. Revenue and Gross Margin 117
      • 7.10.3. Product portfolio 118
      • 7.10.4. Recent initiatives 119
    • 7.11. Oxford Nanopore Technologies 119
      • 7.11.1. Company Overview 119
      • 7.11.2. Oxford Nanopore Technologies Revenue and Gross Margin 119
      • 7.11.3. Product portfolio 120
      • 7.11.4. Recent initiatives 121
    • 7.12. Pacific Biosciences of California Inc. 121
      • 7.12.1. Company Overview 121
      • 7.12.2. Pacific Biosciences of California Inc. Revenue and Gross Margin 121
      • 7.12.3. Product portfolio 122
      • 7.12.4. Recent initiatives 123
    • 7.13. QIAGEN 123
      • 7.13.1. Company Overview 123
      • 7.13.2. QIAGEN Revenue and Gross Margin 123
      • 7.13.3. Product portfolio 124
      • 7.13.4. Recent initiatives 125
    • 7.14. Roche Sequencing 125
      • 7.14.1. Company Overview 125
      • 7.14.2. Roche Sequencing Revenue and Gross Margin 125
      • 7.14.3. Product portfolio 126
      • 7.14.4. Recent initiatives 127
    • 7.15. SciGenom Labs Pvt. Ltd. 127
      • 7.15.1. Company Overview 127
      • 7.15.2. SciGenom Labs Pvt. Ltd. Revenue and Gross Margin 127
      • 7.15.3. Product portfolio 128
      • 7.15.4. Recent initiatives 129
    • 7.16. Thermo Fischer Scientific 129
      • 7.16.1. Company Overview 129
      • 7.16.2. Thermo Fischer Scientific Revenue and Gross Margin 129
      • 7.16.3. Product portfolio 130
      • 7.16.4. Recent initiatives 131
  • Chapter 8. Next Generation Sequencing (NGS) — Industry Analysis 132
    • 8.1. Next Generation Sequencing (NGS) Market – Key Trends 132
      • 8.1.1. Market Drivers 133
      • 8.1.2. Market Restraints 133
      • 8.1.3. Market Opportunities 134
    • 8.2. Value Chain Analysis 135
    • 8.3. Technology Roadmap and Timeline 136
    • 8.4. Next Generation Sequencing (NGS) Market – Attractiveness Analysis 137
      • 8.4.1. By Products and Services 137
      • 8.4.2. By Application 137
      • 8.4.3. By End-User 138
      • 8.4.4. By Region 140
  • Chapter 9. Marketing Strategy Analysis, Distributors 141
    • 9.1. Marketing Channel 141
    • 9.2. Direct Marketing 142
    • 9.3. Indirect Marketing 142
    • 9.4. Marketing Channel Development Trend 142
    • 9.5. Economic/Political Environmental Change 143
  • Chapter 10. Report Conclusion 144
  • Chapter 11. Research Approach & Methodology 145
    • 11.1. Report Description 145
    • 11.2. Research Scope 146
    • 11.3. Research Methodology 146
      • 11.3.1. Secondary Research 147
      • 11.3.2. Primary Research 148
      • 11.3.3. Models 149
        • 11.3.3.1. Company Share Analysis Model 149
        • 11.3.3.2. Revenue Based Modeling 150
        • 11.3.3.3. Research Limitations 150

List of Figures

FIG. 1 Global Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 25
FIG. 2 Global Next Generation Sequencing (NGS) Market Share, by Products and Services, 2018 & 2025 (USD Million) 26
FIG. 3 Global Products by Technology Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 28
FIG. 4 Global Sequencing Services by Type Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 29
FIG. 5 Global Next Generation Sequencing (NGS) Market Share, by Application, 2018 & 2025 (USD Million) 30
FIG. 6 Global Bioinformatics Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 31
FIG. 7 Global Genetic Research Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 32
FIG. 8 Global Diagnostics Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 33
FIG. 9 Global Agriculture & Animal Research Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 34
FIG. 10 Global Drug Discovery Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 35
FIG. 11 Global Next Generation Sequencing (NGS) Market Share, by End-User, 2018 & 2025 (USD Million) 36
FIG. 12 Global Research Institutes Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 37
FIG. 13 Global Academic Institutes Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 38
FIG. 14 Global Pharmaceuticals Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 39
FIG. 15 Global Hospitals Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 40
FIG. 16 Global Biotechnology Companies Next Generation Sequencing (NGS) Market, 2015-2027 (USD Million) 41
FIG. 17 Global Next Generation Sequencing (NGS) Market Share, by Region, 2018 & 2025 42
FIG. 18 North America Next Generation Sequencing (NGS) Market, 2015-2027 44
FIG. 19 U.S. Next Generation Sequencing (NGS) Market, 2015-2027 49
FIG. 20 Canada Next Generation Sequencing (NGS) Market, 2015-2027 50
FIG. 21 Mexico Next Generation Sequencing (NGS) Market, 2015-2027 51
FIG. 22 Europe Next Generation Sequencing (NGS) Market, 2015-2027 52
FIG. 23 Germany Next Generation Sequencing (NGS) Market, 2015-2027 57
FIG. 24 France Next Generation Sequencing (NGS) Market, 2015-2027 58
FIG. 25 U.K. Next Generation Sequencing (NGS) Market, 2015-2027 59
FIG. 26 Italy Next Generation Sequencing (NGS) Market, 2015-2027 60
FIG. 27 Spain Next Generation Sequencing (NGS) Market, 2015-2027 61
FIG. 28 Nordic Countries Next Generation Sequencing (NGS) Market, 2015-2027 62
FIG. 29 Benelux Union Next Generation Sequencing (NGS) Market, 2015-2027 63
FIG. 30 Rest of Europe Next Generation Sequencing (NGS) Market, 2015-2027 64
FIG. 31 Asia Pacific Next Generation Sequencing (NGS) Market, 2015-2027 65
FIG. 32 China Next Generation Sequencing (NGS) Market, 2015-2027 70
FIG. 33 Japan Next Generation Sequencing (NGS) Market, 2015-2027 71
FIG. 34 India Next Generation Sequencing (NGS) Market, 2015-2027 72
FIG. 35 New Zealand Next Generation Sequencing (NGS) Market, 2015-2027 73
FIG. 36 Australia Next Generation Sequencing (NGS) Market, 2015-2027 74
FIG. 37 South  Korea Next Generation Sequencing (NGS) Market, 2015-2027 75
FIG. 38 South-East Asia Next Generation Sequencing (NGS) Market, 2015-2027 76
FIG. 39 Rest of Asia Pacific Next Generation Sequencing (NGS) Market, 2015-2027 77
FIG. 40 Latin America Next Generation Sequencing (NGS) Market, 2015-2027 78
FIG. 41 Brazil Next Generation Sequencing (NGS) Market, 2015-2027 83
FIG. 42 Argentina Next Generation Sequencing (NGS) Market, 2015-2027 84
FIG. 43 Rest of Latin America Next Generation Sequencing (NGS) Market, 2015-2027 85
FIG. 44 The Middle-East and Africa Next Generation Sequencing (NGS) Market, 2015-2027 86
FIG. 45 Saudi Arabia Next Generation Sequencing (NGS) Market, 2015-2027 91
FIG. 46 UAE Next Generation Sequencing (NGS) Market, 2015-2027 92
FIG. 47 Egypt Next Generation Sequencing (NGS) Market, 2015-2027 93
FIG. 48 Kuwait Next Generation Sequencing (NGS) Market, 2015-2027 94
FIG. 49 South Africa Next Generation Sequencing (NGS) Market, 2015-2027 95
FIG. 50 Rest of Middle-East Africa Next Generation Sequencing (NGS) Market, 2015-2027 96
FIG. 51 Competitor Market Share – Revenue 97
FIG. 52 ABM Inc. Revenue and Growth Rate 102
FIG. 53 ABM Inc. Market Share 102
FIG. 54 Agilent Technologies Inc. Revenue and Growth Rate 104
FIG. 55 Agilent Technologies Inc. Market Share 104
FIG. 56 BD Revenue and Growth Rate 106
FIG. 57 BD Market Share 106
FIG. 58 BGI Revenue and Growth Rate 108
FIG. 59 BGI Market Share 108
FIG. 60 DNASTAR Revenue and Growth Rate 110
FIG. 61 DNASTAR Market Share 110
FIG. 62 Eurofins Genomics Revenue and Growth Rate 112
FIG. 63 Eurofins Genomics Market Share 112
FIG. 64 F. Hoffmann-La Roche Ltd. Revenue and Growth Rate 114
FIG. 65 F. Hoffmann-La Roche Ltd. Market Share 114
FIG. 66 Illumina Inc. Revenue and Growth Rate 116
FIG. 67 Illumina Inc. Market Share 116
FIG. 68 LGC Limited Revenue and Growth Rate 118
FIG. 69 LGC Limited Market Share 118
FIG. 70 Macrogen Inc. Revenue and Growth Rate 120
FIG. 71 Macrogen Inc. Market Share 120
FIG. 72 Oxford Nanopore Technologies Revenue and Growth Rate 122
FIG. 73 Oxford Nanopore Technologies Market Share 122
FIG. 74 Pacific Biosciences of California Inc. Revenue and Growth Rate 124
FIG. 75 Pacific Biosciences of California Inc. Market Share 124
FIG. 76 QIAGEN Revenue and Growth Rate 126
FIG. 77 QIAGEN Market Share 126
FIG. 78 Roche Sequencing Revenue and Growth Rate 128
FIG. 79 Roche Sequencing Market Share 128
FIG. 80 SciGenom Labs Pvt. Ltd. Revenue and Growth Rate 130
FIG. 81 SciGenom Labs Pvt. Ltd. Market Share 130
FIG. 82 Thermo Fischer Scientific Revenue and Growth Rate 132
FIG. 83 Thermo Fischer Scientific Market Share 132
FIG. 84 Market Dynamics 134
FIG. 85 Global Next Generation Sequencing (NGS) – Value Chain Analysis 137
FIG. 86 Technology Roadmap and Timeline 138
FIG. 87 Market Attractiveness Analysis – By Products and Services 139
FIG. 88 Market Attractiveness Analysis – By Application 140
FIG. 89 Market Attractiveness Analysis – By End-User 140
FIG. 90 Market Attractiveness Analysis – By Region 142
FIG. 91 Market Channel 143
FIG. 92 Marketing Channel Development Trend 144
FIG. 93 Growth in World Gross Product, 2008-2018 145

List of Tables

TABLE 1 Global Next Generation Sequencing (NGS) Market, 2018 & 2025 (USD Million) 23
TABLE 2 Global Next Generation Sequencing (NGS) market, by Products and Services, 2015-2027 (USD Million) 26
TABLE 3 Global Next Generation Sequencing (NGS) market, by Application, 2015-2027 (USD Million) 30
TABLE 4 Global Next Generation Sequencing (NGS) market, by End-User, 2015-2027 (USD Million) 36
TABLE 5 Global Next Generation Sequencing (NGS) market, by Region, 2015-2027 (USD Million) 42
TABLE 6 North America Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 46
TABLE 7 North America Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 47
TABLE 8 North America Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 48
TABLE 9 Europe Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 54
TABLE 10 Europe Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 55
TABLE 11 Europe Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 56
TABLE 12 Asia Pacific Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 67
TABLE 13 Asia Pacific Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 68
TABLE 14 Asia Pacific Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 69
TABLE 15 Latin America Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 80
TABLE 16 Latin America Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 81
TABLE 17 Latin America Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 82
TABLE 18 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Products and Services, 2015-2027 (USD Million) 88
TABLE 19 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by Application, 2015-2027 (USD Million) 89
TABLE 20 The Middle-East and Africa Next Generation Sequencing (NGS) Market, by End-User, 2015-2027 (USD Million) 90
TABLE 21 Global Next Generation Sequencing (NGS) Market - Company Revenue Analysis 2015-2018 (USD Million) 97
TABLE 22 Global Next Generation Sequencing (NGS) Market - Company Revenue Share Analysis 2015-2018(%) 99
TABLE 23 Acquisitions and Mergers 100
TABLE 24 New Product/Service Launch 100
TABLE 25 Research & Development Activities 100
TABLE 26 Market Drivers 135
TABLE 27 Market Restraints 135
TABLE 28 Market Opportunities 136

Industry Major Market Players

  • The key players included in this market are ABM Inc., 
  • Agilent Technologies Inc., 
  • BD, 
  • BGI, 
  • DNASTAR, 
  • Eurofins Genomics, 
  • F. Hoffmann-La Roche Ltd., 
  • Illumina Inc., 
  • LGC Limited, 
  • Macrogen Inc., 
  • Oxford Nanopore Technologies, 
  • Pacific Biosciences of California Inc. QIAGEN, 
  • Roche Sequencing, 
  • SciGenom Labs Pvt. Ltd., 
  • Thermo Fischer Scientific.

Related Reports

Vacutainer Market By Type (Serum Separating Tubes, EDTA Tubes, Plasma Separation Tubes, and Others), By Application (Venous Blood Collection, and Capillary Blood Collection): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specialized and expertise oriented industry research report scrutinizes the technical and commercial business outlook of the vacutainer industry. The report analyzes and declares the historical and current trends analysis of the Vacutainer industry and subsequently recommends the projected tr...Read More

Mar-2020 | Price : $ 3850.00 | Pages: 189 | Report Code: ZMR-820 | Report Format:

MicroRNA Market By Application(Clinical Diagnostics and Research) and By End Use(Research and Academic Institutes, Contract Research Organizations, Biopharmaceutical Companies, and Diagnostic Centers):Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026

This specializedandexpertise oriented industry research report scrutinizes the technical and commercial business outlook of the MicroRNA industry. The report analyzes and declares the historical and current trends analysis of the MicroRNA industry and subsequently recommends the projected trends a...Read More

Mar-2020 | Price : $ 3850.00 | Pages: 180 | Report Code: ZMR-766 | Report Format:

RNAi for the Therapeutics Market by Type (siRNA, miRNA, and shRNA), and By Sales Channel (Direct & Distributor) for Cancer, Ocular Disorder, HBV and Others: Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2026

The report encompasses the forecast as well as analysis of the RNAi for the Therapeuticsmarket on the global and regional levels. The study displays historical data of 2016 to 2019along with a forecast from 2020 to 2026 based on revenue (USD Million). Additionally, the market growth drivers, oppor...Read More

Feb-2020 | Price : $ 3850.00 | Pages: 110 | Report Code: ZMR-503 | Report Format:

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions